ATE109202T1 - Avirulenter vibrio cholerae und verfahren zu seiner herstellung. - Google Patents

Avirulenter vibrio cholerae und verfahren zu seiner herstellung.

Info

Publication number
ATE109202T1
ATE109202T1 AT84301278T AT84301278T ATE109202T1 AT E109202 T1 ATE109202 T1 AT E109202T1 AT 84301278 T AT84301278 T AT 84301278T AT 84301278 T AT84301278 T AT 84301278T AT E109202 T1 ATE109202 T1 AT E109202T1
Authority
AT
Austria
Prior art keywords
vibrio cholerae
production
avirulent
avirulent vibrio
cholerae
Prior art date
Application number
AT84301278T
Other languages
English (en)
Inventor
James B Kaper
Myron M Levine
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of ATE109202T1 publication Critical patent/ATE109202T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/107Vibrio
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/63Vibrio
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/909Vibrio

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT84301278T 1983-03-04 1984-02-28 Avirulenter vibrio cholerae und verfahren zu seiner herstellung. ATE109202T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47227683A 1983-03-04 1983-03-04
US06/581,406 US5135862A (en) 1983-03-04 1984-02-17 Method of isolating restriction fragment deletions in vibrio cholerae, products thereof

Publications (1)

Publication Number Publication Date
ATE109202T1 true ATE109202T1 (de) 1994-08-15

Family

ID=27043715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84301278T ATE109202T1 (de) 1983-03-04 1984-02-28 Avirulenter vibrio cholerae und verfahren zu seiner herstellung.

Country Status (8)

Country Link
US (1) US5135862A (de)
EP (2) EP0119031B1 (de)
AT (1) ATE109202T1 (de)
AU (1) AU566528B2 (de)
CA (1) CA1324968C (de)
DE (1) DE3486326T2 (de)
DK (1) DK151284A (de)
HK (1) HK86595A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882653A (en) * 1983-03-04 1999-03-16 The University Of Maryland System Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof
US5399494A (en) * 1983-03-04 1995-03-21 The University Of Maryland System Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom
US5470729A (en) * 1983-03-04 1995-11-28 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
US4882278A (en) * 1983-04-29 1989-11-21 President And Fellows Of Harvard College Non-toxinogenic vibrio cholerae mutants
JPS622474A (ja) * 1985-06-27 1987-01-08 アンプ インコ−ポレ−テツド コネクタ
SE462285B (sv) * 1988-09-16 1990-05-28 Jan Roland Holmgren Expression av koleratoxinets bindande subenhet med hjaelp av fraemmande promotor- och/eller ledarpeptidstrukturer
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
CA2064046C (en) * 1990-06-05 1999-04-13 James B. Kaper Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof
US6203799B1 (en) * 1993-07-01 2001-03-20 Presidents And Fellows Of Harvard College Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit
CN1104907C (zh) * 1993-10-08 2003-04-09 巴尔的摩马里兰大学 霍乱弧菌01(cvd111)和非01(cvd112和cvd112rm)血清型疫苗菌株, 其制造方法
EP0928831B1 (de) * 1997-12-10 2006-05-03 Council of Scientific and Industrial Research Choleraorganismen, Impfstoffe und ihre Verwendung
RU2169187C1 (ru) * 2000-04-26 2001-06-20 Федеральное государственное учреждение Российский научно-исследовательский противочумный институт "Микроб" Министерства здравоохранения РФ Штамм бактерий vibrio cholerae 2414 классического биовара серовара огава - продуцент холерного токсина и токсинкорегулируемых пилей адгезии
TWI608990B (zh) * 2015-11-26 2017-12-21 國立交通大學 用於製備氫氣之觸媒組成物、其製法及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264737A (en) * 1978-09-21 1981-04-28 President And Fellows Of Harvard College Method of making genetically stable mutants of vibrio cholerae
US4328209A (en) * 1979-04-11 1982-05-04 Board Of Regents, The University Of Texas System Cholera vaccine
US4935364A (en) * 1983-03-04 1990-06-19 Swiss Serum And Vaccine Institute Berne Method of isolating restriction fragment deletions in vibrio cholerae and products thereof
US4882278A (en) * 1983-04-29 1989-11-21 President And Fellows Of Harvard College Non-toxinogenic vibrio cholerae mutants

Also Published As

Publication number Publication date
DK151284D0 (da) 1984-03-02
EP0119031B1 (de) 1994-07-27
EP0581329A1 (de) 1994-02-02
EP0119031A3 (en) 1985-09-18
AU566528B2 (en) 1987-10-22
DK151284A (da) 1984-09-05
DE3486326D1 (de) 1994-09-01
CA1324968C (en) 1993-12-07
EP0119031A2 (de) 1984-09-19
US5135862A (en) 1992-08-04
DE3486326T2 (de) 1994-11-17
AU2519584A (en) 1984-09-06
HK86595A (en) 1995-06-09

Similar Documents

Publication Publication Date Title
ATE109202T1 (de) Avirulenter vibrio cholerae und verfahren zu seiner herstellung.
ATE92030T1 (de) Verfahren zur herstellung von vinylacetat.
ATE11106T1 (de) Bromhexin-retardform und verfahren zu ihrer herstellung.
DE3889129D1 (de) Methode zum Modifizieren des Nebenproduktes eines Abgassbehandlungsprozesses.
ATE11203T1 (de) Verfahren zur herstellung eines kollagenschlammes.
DE68915664D1 (de) Verfahren zur Herstellung von Rohreinheiten.
ATA128184A (de) Verfahren zur enzymatischen behandlung von vorentsafteter maische
ATE118817T1 (de) Verfahren zur herstellung von xbai- restriktionsendonuklease und -methylase.
ATA144682A (de) Verfahren zur herstellung von neuen benzoylderivaten von aliphatischen carbonsaeuren
DE3772341D1 (de) Verfahren zur herstellung von carbonsaeuren.
DE3870421D1 (de) Verfahren zur herstellung von zerkleinerten fleischprodukten.
DE3888648D1 (de) Verfahren zur Herstellung von HgiAI-Restriktionsendonuklease und -methylase.
DE3761373D1 (de) Verfahren zur herstellung von fluor enthaltenden alpha,beta-ungesaettigten carbonsaeuren.
DE3872007D1 (de) Verfahren zur herstellung von carbonsaeuren.
ES8603952A1 (es) Un metodo de aislar mutantes por supresion de vibrio cholerae
ATE13049T1 (de) Verfahren zur herstellung von methyl tert-butyl aether und aethyl tert-butyl aether.
DE3486168D1 (de) Verfahren zur herstellung von l-glutaminsaeure durch fermentation und dabei zu verwendende mutante mikroorganismen.
ATE13421T1 (de) Verfahren zur herstellung von 4-aminobutters|ureamide.
ATE101647T1 (de) Verfahren zur herstellung von aseirestriktionsendonuklease und -methylase.
DE3850056D1 (de) Verfahren zur Regeneration von desaktivierten Mikroorganismen.
DE3785032D1 (de) Carbonsaeuregemisch und verfahren zu seiner herstellung.
DE3868160D1 (de) Verfahren zur herstellung von carbonsaeuren.
ZA818114B (en) Method for the recovery of enzymes after the treatment of starch-containing raw materials used for the production of fermentation alcohol
DD200654A1 (de) Verfahren zur schonenden gewinnung von proteinen aus mikroorganismen
ATA165184A (de) Verfahren zur herstellung von neuen 4-(4,4-bis-(p-fluorphenyl)-butyl)-1-carbophenox -piperazinen und von 1-piperazincarboxamiden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time